RHÖN-KLINIKUM Aktiengesellschaft28.05.2020 / 16:00 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings1. Details of issuer | Name: | RHÖN-KLINIKUM Aktiengesellschaft | | Street: | Salzburger Leite 1 | | Postal code: | 97616 | | City: | Bad Neustadt a.d.SaaleGermany | | Legal Entity Identifier (LEI): | 529900MVGMIVUDQY9E20 |
2. Reason for notification | X | Acquisition/disposal of shares with voting rights | | X | Acquisition/disposal of instruments | | | Change of breakdown of voting rights | | | Other reason: |
3. Details of person subject to the notification obligation | Natural person (first name, surname): Dr. Bernard große BroermannDate of birth: 20 Nov 1943 |
4. Names of shareholder(s)holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:6. Total positions | | % of voting rights attached to shares (total of 7.a.) | % of voting rights through instruments (total of 7.b.1 + 7.b.2) | Total of both in % (7.a. + 7.b.) | Total number of voting rights pursuant to Sec. 41 WpHG | | New | 42.95 % | 7.66 % | 50.07 % | 66962470 | | Previous notification | 28.99 % | 49.77 % | 50.07 % | / |
7. Details on total positionsa. Voting rights attached to shares (Sec. 33, 34 WpHG) | ISIN | Absolute | In % | | | Direct (Sec. 33 WpHG) | Indirect (Sec. 34 WpHG) | Direct (Sec. 33 WpHG) | Indirect (Sec. 34 WpHG) | | DE0007042301 | 360 | 28,763,252 | 0.0005 % | 42.95 % | | Total | 28,763,612 | 42.95 % |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % | | Right to transfer shares under share purchase agreement of 28 February 2020 | | | 4,405,517 | 6.58 % | | Right to transfer shares under share purchase agreement of 1 March 2020 | | | 361,430 | 0.54 % | | | | Total | 4,766,947 | 7.12 % |
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % | | contribution obligation subject to a condition precedent under joint venture agreement | | | | 4,405,517 | 6.58 % | | contribution obligation subject to a condition precedent under joint venture agreement | | | | 722,860 | 1.08 % | | | | | Total | 5,128,377 | 7.66 % |
8. Information in relation to the person subject to the notification obligation | | Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). | | X | Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) | | Dr. Benard große Broermann | % | % | % | | Asklepios KlinikenManagement GmbH | % | % | % | | Asklepios Kliniken GmbH & Co. KGaA | % | % | % | | AMR Holding GmbH | 42.11 % | 7.66 % | 49.77 % | | | | | | | Dr. Bernard große Broermann | % | % | % | | Broermann Holding GmbH | % | % | % | | Asklepios Kliniken GmbH & Co. KGaA | % | % | % | | AMR Holding GmbH | 42.11 % | 7.66 % | 49.77 % |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting: | Proportion of voting rights | Proportion of instruments | Total of both | | % | % | % |
10. Other explanatory remarks: | The Asklepios Kliniken GmbH & Co. KGaA ("Asklepios") acquired a shareholding in RHÖN-KLINIKUM AG ("RHÖN") of 5.81% (from a total of 12.39%) on 26.5.2020 based on the share purchase agreement with E. Münch and I. Münch dated 28.2.2020 and contributed this to AMR Holding GmbH ("AMR") on the same day together with the RHÖN shares already held directly by Asklepios (34.49% in total) in accordance with the joint venture agreement dated 28.2.2020 ("JVV"). On 26.5.2020, HCM SE contributed a 7.61% stake to AMR in accordance with the JVV. On 26.5.2020, Asklepios acquired a shareholding of 0.54% (of a total of 1.08%) based on the share purchase agreement with the Münch Foundation dated 1.3.2020. Asklepios is obliged under the JVV to contribute this shareholding to AMR. To avoid double counting, the voting rights and instruments held by Asklepios were offset according to section 38 (1) sentence 1 of the WpHG and the instruments held by AMR according to section 38 (1) sentence 1 no. 2 of the WpHG. |
Date
28.05.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
| Language: | English |
| Company: | RHÖN-KLINIKUM Aktiengesellschaft |
| Salzburger Leite 1 |
| 97616 Bad Neustadt a.d.Saale |
| Germany |
| Internet: | www.rhoen-klinikum-ag.com |
